Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NLS Pharmaceutics AG

    NASDAQ: NLSP · Real-Time Price · USD
    2.54
    -0.07 (-2.68%)
    At close: Aug 15, 2025, 3:59 PM
    2.58
    1.58%
    After-hours: Aug 15, 2025, 07:55 PM EDT

    NLS Pharmaceutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Cash & Equivalents
    		 552.76K 897.68K 1.65M 8.95M 1.35M 5.43M 7.09M
    Short-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 0.00 16.89K 12.56K 12.14K 11.73K 12.04K n/a
    Receivables
    		 31.57K 10.66K n/a n/a n/a n/a n/a
    Inventory
    		 n/a n/a -64.28K -41.24K -59.83K -38.55K -43.08K
    Other Current Assets
    		 310.85K n/a 102.1K n/a n/a n/a n/a
    Total Current Assets
    		 1.19M 1.82M 2.25M 9.25M 2.02M 5.72M 8.24M
    Property-Plant & Equipment
    		 990.00 6.69K 12.4K 18.1K 23.81K 29.51K 27.73K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 990.00 23.58K 24.95K 30.25K 35.54K 41.55K 27.73K
    Total Assets
    		 1.19M 1.85M 2.27M 9.28M 2.06M 5.76M 8.27M
    Account Payables
    		 4.58M 4.63M 3.11M 2.37M 2.52M 1.74M 527.2K
    Deferred Revenue
    		 n/a n/a n/a n/a n/a 2.5B n/a
    Short-Term Debt
    		 1.71M 1.63M n/a n/a 354.34K n/a n/a
    Other Current Liabilities
    		 277.77K 112.64K -19.32K 8.89K 33.24K 10.08K n/a
    Total Current Liabilities
    		 7.72M 7.92M 3.89M 3.36M 3.41M 2.4M 1.19M
    Long-Term Debt
    		 n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 243.63K 260.68K 164.62K 136.12K 188.76K 318.89K 327.32K
    Total Long-Term Liabilities
    		 2.74M 2.76M 2.66M 2.64M 2.69M 2.82M 2.83M
    Total Liabilities
    		 10.46M 10.68M 6.56M 6M 6.1M 5.22M 4.02M
    Total Debt
    		 1.71M 1.63M n/a n/a 354.34K n/a n/a
    Common Stock
    		 808.55K 733.41K 733.41K 668.55K 411.27K 344.44K 259.73K
    Retained Earnings
    		 -72.41M -70.37M -65.81M -58.2M -50.35M -41.71M -34.36M
    Comprehensive Income
    		 4.21K -158.07K -66.22K -50.79K -32.71K -151.74K -179.85K
    Shareholders Equity
    		 -9.27M -8.83M -4.29M 3.28M -4.04M 542.39K 4.25M
    Total Investments
    		 n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist